Chemotherapeutic agents simultaneously induce transcription factors p53 and NFB. p53 induction can activate an apoptotic program, and resistance to chemotherapy correlates with the loss of a functional p53 pathway. By contrast, NFB prevents apoptosis in response to chemotherapeutic agents. We have analyzed the p53 response in IKK1/2 Ϫ/Ϫ MEFs, which lack detectable NFB activity. Compared to WT fibroblasts, IKK1/2 Ϫ/Ϫ fibroblasts showed increased cell death and p53 induction in response to the chemotherapeutic agent, doxorubicin. Reconstitution of IKK2, but not IKK1, increased Mdm2 levels and decreased doxorubicin-induced p53 stabilization and cell death. IKK2-mediated effects required its kinase function and were abrogated by coexpression of the dominant negative IB␣M, implying a role for NFB in blocking chemotherapy-induced p53 and cell death.
Introduction
for regulating this degradation (Haupt et al., 1997; Honda and Yasuda, 1999; Kubbutat et al., 1997) . Mutant forms of p53 accumulate in cells because they fail to transcriptionally activate Cytotoxicity of chemotherapeutic agents has been attributed to apoptosis, a form of programmed cell death (Chao et al., 2000) .
Mdm2. The loss of a wild-type p53 response creates a permissive environment for acquisition of genomic instability (Yin et However, acquisition of resistance to the cytotoxic effects of chemotherapy has emerged as a significant impediment to efal., 1992) , which can lead to secondary mutations that can engender resistance to the cytotoxicity of chemotherapeutic fective cancer therapy. The tumor suppressor protein p53, a sequence-specific transcription factor, is a key modulator of agents. NFB is a family of ubiquitously expressed dimeric sequence apoptosis in response to chemotherapeutic agents (Levine, 1997; Lowe et al., 1993a) . As p53 plays a central role in sensing specific transcription factors. Initially recognized for controlling gene expression and function in the immune system, the imporand maintaining genetic integrity, its activation and function have been extensively investigated (Levine, 1997; .
tance of NFB family members in modulating cellular growth, apoptosis, and development is now well documented. In most Various cellular signals, including activation of oncogenes (Debbas and White, 1993; Serrano et al., 1997) , DNA damage (Huang unstimulated cells, the NFB dimers are bound in the cytoplasm by inhibitory IB molecules (Verma et al., 1995) . Since transcripet al., 1996) , and hypoxia (Graeber et al., 1994) , lead to activation of p53, resulting in either apoptosis or cell cycle arrest. The tional activation by NFB requires its nuclear translocation, signal-induced degradation of IB molecules is considered a key choice between these outcomes likely depends, among other factors, on the genetic variability (Polyak et al., 1996) and the rate-limiting step in NFB activation (Karin and Ben-Neriah, 2000) . Phosphorylation of IB molecules at specific serine resiextent of p53 activation . Regulation of p53 mainly occurs posttranscriptionally, often via posttranslational dues immediately precedes their ubiquitin-mediated degradation (Chen et al., 1995) . Two serine threonine IB kinases (IKK), modifications that increase its half-life and nuclear concentration (Prives, 1998) . In normal cells, p53 protein is rapidly turned IKK1 and IKK2, which are 52% identical, were identified to be responsible for phosphorylating and targeting IB molecules for over due to ubiquitin-mediated proteolytic degradation (Bottger et al., 1997) . Interaction of p53 with Mdm2, a protein that is degradation. Both IKK1 (also called IKK␣) and IKK2 (also called IKK␤) normally reside in a large Ͼ700 kDa complex in the cytotranscriptionally activated by p53 (Wu et al., 1993) , is crucial plasm. In addition to these two kinases, the IKK complex also WT embryos. Compared to WT MEFs, IKK1/2 Ϫ/Ϫ MEFs were consists of other regulatory proteins (Yamaoka et al., 1998) . A more sensitive to DoxR-induced cell death ( Figure 1A ). Further genetic dissection of the different roles played by these kinases characterization of DoxR mediated cell death in these MEFs has been provided by the generation of IKK1 (Li et al., 1999a;  indicated that cell death resulted from apoptosis (data not Takeda et al., 1999) and IKK2 knockout mice (Li et al., 1999b, shown) . Gel shift analysis to detect the activation of NFB in 1999c; Tanaka et al., 1999) . Mice lacking both IKK1 and IKK2 response to varying doses of DoxR revealed NFB DNA binding die embryonically at day 9.5 (Li et al., 2000) . Unlike murine activity in WT but not in IKK1/2 Ϫ/Ϫ MEFs (data not shown). embryo fibroblasts (MEFs) derived from IKK1 Ϫ/Ϫ and Since p53 plays an important role in DoxR-mediated cell IKK2 Ϫ/Ϫ animals, MEFs derived from IKK1/2 Ϫ/Ϫ double knockout death (Lowe et al., 1993a) , we analyzed the induction of p53 in embryos are severely defective in NFB activation, reiterating WT and IKK1/2 Ϫ/Ϫ MEFs. A titration of DoxR revealed that p53 that these are the two essential kinases involved in NFB activainduction in the IKK1/2 Ϫ/Ϫ MEFs occurred at a lower dose of tion (Li et al., 2000) . DoxR ( Figure 1B , compare lanes 3-6 and 9-12). Similar results Both NFB and p53 are activated in response to many stimwere obtained using two independent sets of WT and IKK1/ uli, including DNA damage (Devary et al., 1993; Wang et al., 2 Ϫ/Ϫ MEFs. Densitometric analysis revealed between 2-5 fold 1996) and TNF␣ (Donato and Perez, 1998) . It is conceivable higher p53 in IKK1/2 Ϫ/Ϫ cells. The levels of p65, IKK1, and IKK2 that these transcription factors, which have been documented remained unchanged upon DoxR titration. RT-PCR analysis reto have largely opposite effects in response to stress, modulate vealed no significant differences in p53 expression between WT each other's activities. Indeed, competition for limiting pools of and IKK1/2 Ϫ/Ϫ cells (data not shown). These results suggest transcriptional coactivators p300 and CBP has been reported that lack of IKK activity sensitizes cells to p53 stabilization in to mediate a bidirectional repression between NFB and p53 response to DoxR. More importantly, induction of p53 is not (Webster and Perkins, 1999) . In addition, transactivation of the dependent on NFB activity. p53 promoter by NFB in response to TNF␣ (Wu and Lozano, To understand the increased sensitivity of IKK1/2 Ϫ/Ϫ MEFs 1994) and anticancer drugs (Hellin et al., 1998; Sun et al., 1995) to DoxR, we evaluated the integrity of the DNA damage-induced has been observed. p53 response in these cells. Phosphorylation of N-terminal serAlthough mutational inactivation of p53 is observed in well ine 18 in murine p53 (corresponding to serine 15 in human p53) over 50% of all human cancers (Hollstein et al., 1994) , a significontributes to p53 activation by DNA damage (Chao et al., cant fraction of cancers express wild-type p53, which may be 2000). Figure 1C demonstrates that DoxR treatment induces inactivated by other mechanisms, such as increased Mdm2 comparable levels of S18 phosphorylation in both WT and expression resulting from gene amplification (Oliner et al., 1992) , IKK1/2 Ϫ/Ϫ MEFs (lanes 2 and 4). Total p53 induction was meaincreased Raf (Ries et al., 2000) , or Akt signaling (Zhou et al., sured by PA421 antibody (top panel, Figure 1C ). We evaluated 2001). One potential additional mechanism might involve the the transactivation potential of the activated p53 by measuring activation of antiapoptotic genes that compete with proapoprotein levels of the cyclin-dependent kinase inhibitor p21, a ptotic pathways activated by p53. NFB is a well-documented key target gene of p53 (el-Deiry et al., 1993) . Figure 1D demonantiapoptotic factor, which is turned on simultaneously along strates that DoxR treatment induced expression of p21 protein with p53 in response to chemotherapeutic agents (Pahl, 1999;  in both WT and IKK1/2 Ϫ/Ϫ MEFs. It is worth noting that there Wang et al., 1996) . Inhibition of NFB has been documented are higher endogenous levels of p21 ( Figure 1D , compare lane to lead to increased efficacy of anticancer drugs (Cusack et 1 and 3) in the IKK1/2 Ϫ/Ϫ MEFs, which is consistent with the al ., 1999, 2001) . In nude mice, tumors derived from HT1080 enhanced p53 stabilization in these MEFs ( Figure 1B ). The subfibrosarcoma cells (Wang et al., 1999) or from the colorectal cellular localization of DoxR-induced p53 and p21 in both WT tumor cell line LoVo are more sensitive to and IKK1/2 Ϫ/Ϫ MEFs is nuclear (data not shown). Retrovirus chemotherapy when NFB activity is also inhibited. Since NFB mediated expression of the dominant negative p53, p53DD impinges on multiple aspects of tumor progression, such as the (Bowman et al., 1996) , partially blocks DoxR-mediated cell control of apoptosis, cell cycle, and cell migration, it is critical death in IKK1/2 Ϫ/Ϫ MEFs ( Figure 1E ). Similarly, p53DD also parto understand the mechanistic basis of the observation that tially blocks cell death in WT MEFs (see below; Figure 5B ). We blocking NFB is a useful means of blocking acquired resistance conclude that DoxR-induced p53 in WT and IKK1/2 Ϫ/Ϫ MEFs to chemotherapy.
is: (1) modified upon DNA damage; (2) transactivation compeIn this study, we have used IKK1/2 Ϫ/Ϫ MEFs to decipher the tent; (3) correctly localized in the cell; and (4) capable of inducing role of IKKs and NFB in regulating the p53 response induced cell death. by the anticancer agent doxorubicin (DoxR). We find that lack of IKK2 activity and the consequent inability to activate NFB Reduction of DoxR-induced cell death and p53 facilitates p53 stabilization and promotes cell death. Our results stabilization by IKK2 not only provide evidence of selectivity in NFB activation by Since the IKK1/2 Ϫ/Ϫ MEFs were sensitive to DoxR-induced cell the IB kinases but also show that IKK2 plays a unique role in death and accumulation of p53, we tested if reconstitution with activating NFB and in compromising p53 function in response IKK1 or IKK2 could reverse p53 accumulation and cell death. to chemotherapy.
IKK1/2 Ϫ/Ϫ cells were infected with recombinant adenoviruses (rAD) expressing IKK1WT (rAD-IKK1WT), the kinase inactive Results IKK1KM (rAD-IKK1KM), IKK2WT (rAD-IKK2WT), and kinase inactive IKK2KM (rAD-IKK2KM). As a control, cells were infected MEFs lacking IKK1 and IKK2 are more sensitive with rAD-GFP, a virus expressing the green fluorescent protein. to DoxR-induced cell death and p53 stabilization Recombinant IKK1 and IKK2 proteins were detected using HA The role of IKK1 and IKK2 in DoxR sensitivity was evaluated using spontaneously immortalized MEFs from IKK1/2 Ϫ/Ϫ and and flag tags, respectively. Only transduction with rAD-IKK2WT A: WT and IKK1/2 Ϫ/Ϫ MEFs were plated in six-well plates and allowed to reach confluence. Cells were treated with 0.7 g/ml DoxR and percentage survival was calculated as described. B: Confluent cells grown in 6-well dishes were treated with varying does of DoxR. Whole cell lysates were prepared in 2ϫ SDS gel loading buffer and subjected to Western blot analysis with the indicated antibodies. C: Confluent WT and IKK1/2 Ϫ/Ϫ MEFs were treated with 0.7 g/ml DoxR and whole cell extracts prepared. Total and Ser-18 phosphorylated p53 levels were detected using clone PA421 and Phospho-p53 (Ser 15) 16G8 antibody, respectively. D: WT and IKK1/2 Ϫ/Ϫ MEFs were treated with 0.5 g/ml of DoxR, and whole cell lysates were prepared and resolved on a 15% gel. Level of p21 induction was detected using p21 (H-164) antibody. E: IKK1/2 Ϫ/Ϫ MEFs were either mock infected or infected with pLXSN-p53DD retrovirus expressing p53DD. Pools of infected cells were treated with DoxR (0.4 g/ml). Forty-eight hours after DoxR addition, surviving cells were stained. The expression of p53DD protein was confirmed using PA421 antibody (data not shown).
dramatically reduced the accumulation of p53 in response to molecular distinction between IKK1 and IKK2 in antagonizing DoxR-induced p53 stabilization, we evaluated the potential of DoxR in IKK1/2 Ϫ/Ϫ cells ( Figure 2A , lane 8). Northern blot analysis ( Figure 2B ) revealed comparable levels of p53 messenger RNA these kinases to activate NFB in IKK1/2 Ϫ/Ϫ cells. Gel shift analysis demonstrated that IKK2 ( Figure 3A , lane 3) but not IKK1 in rAD-GFP, rAD-IKK2WT, and rAD-IKK2KM transduced cells, indicating that IKK2WT-mediated effects on p53 stabilization was able to induce NFB DNA binding in these MEFs. The binding to the Oct-1 probe was used as a loading control for operate at the posttranscriptional level. Furthermore, cells expressing IKK2WT but not IKK1WT or the kinase inactive IKKs the nuclear lysates prepared from IKK1/2 Ϫ/Ϫ cells expressing GFP, IKK1, and IKK2. Treatment of IKK1 Ϫ/Ϫ MEFs with DoxR were also more resistant to DoxR-induced cell death ( Figure 2C ).
To test the generality of our observations, we determined induced NFB DNA binding ( Figure 3B ). Since IKK1 Ϫ/Ϫ cells contain IKK2, activation of NFB in response to DoxR in these whether IKK2WT could block p53 stabilization in response to cells supports the notion that this activity is mediated by IKK2. another anticancer agent, etoposide. We found that IKK2WT reduced p53 stabilization ( Figure 2D ) and cell death (data not IKK2 mediated events require activation of NFB shown) in response to etoposide. We conclude that IKK2 sigWe next tested if IKK2-mediated activation of NFB accounts nificantly antagonizes the ability of anticancer agents like DoxR for the observed difference in the abilities of IKK1 and IKK2 to or etoposide to increase p53 abundance and subsequent aporegulate p53 levels. To address this question, we used cell lines ptosis.
expressing IB␣M, a dominant negative form of IB molecule that blocks NFB activation (Van Antwerp et al., 1996) . The IKK2 but not IKK1 can activate NFB NFB pathway is the only signaling cascade documented to be IKK1/2 Ϫ/Ϫ MEFs were transduced with retroviral constructs pLXSH or pLXSH-IB␣M to generate stable cell lines (IKK1/ modulated by IKK1 and IKK2 in vivo. To better understand the Ϫ/Ϫ MEFs were cultured in six well dishes. Freshly confluent cells were infected with recombinant adenoviruses (rAD), expressing GFP (rAD-GFP), IKK1WT (rAD-IKK1WT), IKK1KM (rAD-IKK1KM), IKK2WT (rAD-IKK2WT), or IKK2KM (rAD-IKK2KM) in 300 l DMEM with 5% FCS and antibiotics. The plates were rocked every 10 min and the infection was allowed to proceed for 2 hr, following which cells were replenished with media without removing the virus. This media was changed with fresh media after overnight incubation at 37ЊC. Forty-eight hours postinfection, cells were treated with DoxR at 0.4 g/ml, whole cell lysates were prepared, and Western blot analysis with the indicated antibodies was performed. IKK1 and IKK2 proteins were detected using antibodies against HA and Flag tags, respectively. B: Northern blot analysis of IKK1/2 Ϫ/Ϫ cells infected with the indicated rADs. Cells were treated with various concentrations of DoxR (shown here is 0.5 g/ml) for 24 hr. A total of 8-10 g of total RNA was analyzed by standard Northern blot hybridization. The complete murine p53 cDNA and a 200 bp fragment of actin were used as probes. C: IKK1/2 Ϫ/Ϫ MEFs were cultured and infected in six-well dishes as before and treated with 0.7 g/ml DoxR. Cell survival was estimated between 60 and 72 hr. D: IKK2 can block etoposide-mediated p53 stabilization. IKK1/2 Ϫ/Ϫ MEFs were infected with rAD-GFP, rAD-IKK2WT, and rAD-IKK2KM as described before. Forty-eight hours postinfection, cells were treated with 100 M etoposide. Total lysates were prepared 20 hr later by directly lysing the cells in 2ϫ SDS gel loading buffer. Western blot analysis was performed for the indicated molecules. Figure 4A , lanes 1-6) confirms its inability to be modified and degraded. These results support expression of p53DD could significantly reduce this death (Figure 5B) . the notion that NFB activity is required for blocking DoxRinduced p53 and cell death.
IKK2 but not IKK1 can upregulate Mdm2
Since the ubiquitin ligase Mdm2 is a key determinant of p53 Endogenous levels of NFB inhibit p53 activation Overexpression of IKK2WT resulted in constitutive levels of nustability, we examined whether IKK2-mediated destabilization of p53 occurred through Mdm2. Reconstitution with IKK2WT clear NFB in both IKK1/2 Ϫ/Ϫ and WT MEFs (data not shown). Although such constitutive NFB activity is seen in various tumor and not IKK1WT upregulated the levels of Mdm2 protein ( Figure  6A , lane 4). However, unlike in IKK1/2 Ϫ/Ϫ or WT cells, overexcells and is important in reducing p53 levels in our assays, we and IKK1/2 Ϫ/Ϫ IB␣M cells (lanes 7-12) were infected with rAD-GFP, rADForty-eight hours postinfection, cells were treated with various concentra-IKK2WT, and rAD-IKK2KM as described above. Forty-eight hours postinfections of DoxR (shown here is 0.5 g/ml), and nuclear extracts were prepared tion, cells were either left untreated or treated with 0.4 g/ml DoxR. p53 and analyzed for NFB DNA binding activity. B: IKK1 Ϫ/Ϫ MEFs were treated levels were measured in whole cell lysates using PA421 antibody. Actin with indicated doses of DoxR and analyzed for gel shift activity. The oct-1 levels were used to normalize for protein loading. Expression of IKK2 and probe was used as loading control.
IB␣ proteins was measured using the Flag M2 and IB␣ (C-21) antibodies, respectively. B: IKK1/2 Ϫ/Ϫ Hygro and IKK1/2 Ϫ/Ϫ IB␣M were infected with rAD-GFP, rAD-IKK2WT, and rAD-IKK2KM as described and treated with 0.7 g/ ml DoxR 48 hr postinfection. Cell survival was estimated as described before.
pression of IKK2WT in p53 Ϫ/Ϫ did not lead to upregulation of Mdm2 ( Figure 6B , compare lanes 2 and 5). Transducing IKK1/2 Ϫ/Ϫ Hygro cells with increasing MOI of rAD-IKK2WT but not IKK2KM increased the levels of Mdm2 RNA in caused a concomitant increase in the levels of Mdm2 protein IKK1/2 Ϫ/Ϫ MEFs ( Figure 7C ). Unlike in WT and IKK1/2 Ϫ/Ϫ MEFs, ( Figure 6C , lanes 2-6), which was blocked by coexpression of overexpression of IKK2WT in p53 Ϫ/Ϫ MEFs did not lead to in-IB␣M ( Figure 6C, lanes 8-12) , implicating that NFB activity is crease in Mdm2 RNA (data not shown). These results suggest essential for IKK2-mediated upregulation of Mdm2. Comparable that IKK2WT-mediated increase of Mdm2 mRNA requires p53 levels of IKK2 were expressed in both cell types ( Figure 6C , activity, and that the observed upregulation of Mdm2 protein lanes 2-6 and 8-12). Notably, levels of p53 at a constant dose by IKK2 most likely results from increased levels of its mRNA. of DoxR were much lower in IKK1/2 Ϫ/Ϫ Hygro cells ( Figure 6C , To test if Mdm2 is a direct target of NFB, we stimulated lanes 2-6) than in the corresponding IKK1/2 Ϫ/Ϫ IB␣M cells (Fig- WT and IKK1/2 Ϫ/Ϫ cells with TNF␣, a potent activator of NFB. ure 6C, lanes 8-12), once again indicating increased p53 levels As expected, TNF␣ treatment increased levels of NFB target in the absence of NFB activity.
gene IB␣ in WT but not in IKK1/2 Ϫ/Ϫ cells ( Figure 7D ). However, we did not observe an increase in Mdm2 RNA in this time scale Modulation of Mdm2 messenger RNA levels ( Figure 7D ). Treatment of IKK1/2 Ϫ/Ϫ cells with DoxR demonNorthern blot analysis consistently revealed lower steady-state strated comparable or higher levels of Mdm2 in cells expressing levels of Mdm2 mRNA in IKK1/2
Ϫ/Ϫ (data not shown), IKK2WT ( Figure 7E , compare lanes 2, 4, and 6). We conclude and p53 Ϫ/Ϫ MEFs compared to WT MEFs ( Figure 7A ). Based that IKK2-mediated NFB activation modulates basal levels of on densitometric quantification, IKK1/2 Ϫ/Ϫ had 40% less Mdm2 Mdm2, and additionally contributes to Mdm2 induction following DNA damage. mRNA than WT MEFs ( Figure 7B ). Reconstitution with IKK2WT induction in response to DoxR (Figure 1 ) and etoposide ( Figure  2 ). Reconstitution of IKK2 but not IKK1 can block this sensitivity to p53 stabilization (Figure 2 ). Since IKK2 does not downregulate the endogenous p53 promoter ( Figure 2B ) and upregulates Mdm2 expression ( Figure 6A ), our results indicate that IKK2 suppresses stabilization of the p53 protein. In addition to a role in cancer treatment, IKK2-mediated regulation of Mdm2 and p53 may have important implications in tumor progression. In tumors with wild-type p53, NFB-induced Mdm2 might attenuate the p53 response in early phases of tumor development. NFB-induced Mdm2 overexpression could also counter mutant forms of p53 that retain some p53 functions (Friedlander et al., 1996) . Finally, given that p53-independent transformation properties of Mdm2 have been reported (Cordon-Cardo et al., 1994) , NFB-induced Mdm2 might contribute to tumor progression in a p53-independent manner. NFB has been shown to protect against a variety of cellular insults (Baichwal and Baeuerle, 1997) . Antiapoptotic genes including scavenger enzyme MnSOD, inhibitors of apoptosis c-IAP1 and c-IAP2, Bcl-2 homologs such as Bfl1/A1 and Bcl-x, and the transcription factor A20 have been proposed to mediate NFB dependent survival signals (Barkett and Gilmore, 1999) . Intuitively, the IKK1/2 Ϫ/Ϫ MEFs would fail to activate these NFB dependent antiapoptotic genes which might be required for protection against both p53 dependent and independent cell death. While reconstitution of IKK2 and thus NFB activity in IKK1/2 Ϫ/Ϫ MEFs should reconstitute the function of these antiapoptotic genes, the exact contribution of NFB in specifically repressing p53 dependent cell death in IKK1/2 Ϫ/Ϫ MEFs remains vivo (Li et al., 1999a (Li et al., , 1999b . However, given that these kinases IKK2 is crucial for IB␣ degradation, IKK1 has recently been cells were treated with 0.7 g/ml DoxR and cell survival was estimated as postulated to be required for a second NFB-activating pathway described previously. (Senftleben et al., 2001) . In this study we have reconstituted IKK1 and IKK2 in cells lacking both these kinases. Our results clearly demonstrate that IKK2 is both necessary and sufficient to activate NFB ( Figure 3 ) and block p53 stabilization and cell Discussion death in a NFB-dependent manner (Figure 4 ). Genetic analysis using IKK2 Ϫ/Ϫ MEFs had revealed that IKK1 homodimers can Cell proliferation reflects the interplay of cell survival and cell activate NFB DNA binding in response to TNF␣ (Li et al., death pathways. It is becoming apparent that the effectiveness 1999b). The inability of IKK1 to activate NFB activity in reof chemotherapeutic agents may similarly reflect their relative sponse to DoxR in our assay could indicate that unlike IKK2, abilities to paradoxically activate cell death and cell survival IKK1-mediated NFB activation might occur only in response pathways. p53 has been demonstrated to be important for modto selective upstream signals. These results reiterate that apart ulating cell death in response to chemotherapeutic agents (Lowe from activating different signaling cascades in vivo, distinct geet al., 1993a). However, a correlation between wild-type status netic roles of these kinases could also be reflective of their of p53 and response to chemotherapy is not uniformly observed differential abilities to activate NFB. Designing IKK1 and IKK2 in tumors. In part, this is due to alterations in other factors that specific inhibitors could be instrumental in selectively blocking regulate p53 abundance or function, such as amplification of NFB in response to distinct upstream signals. Mdm2 (Oliner et al., 1992) and HER-2/neu (Zhou et al., 2001) , Hodgkins lymphoma (Sovak et al., 1997) and breast cancer and mutations/deletions in INK4a/ARF loci (Sherr, 1998) . Addi- (Nakshatri et al., 1997) cell lines have constitutively elevated tional mutations and genetic variability might be other crucial modifiers of a tumor's response to chemotherapy. The findings levels of nuclear NFB. Blocking of NFB activity has been shown to inhibit ras mediated transformation (Mayo et al., 1997) . presented in this paper implicate the NFB signaling cascade as a potential modulator of p53 in response to chemotherapy.
In addition, human T cell leukemia virus type 1 (HTLV-1) (Sun and Ballard, 1999) 
and Epstein-Barr virus (EBV) (Cahir McFarland et We demonstrate that IKK1/2
Ϫ/Ϫ cells that are severely defective in NFB activity are more sensitive to cell death and p53 al., 1999) are some of the viruses that induce the activity of NFB during cellular transformation. Cumulatively, consistent p53 Ϫ/Ϫ cells. Since the p53 promoter has been documented to be upregulated by NFB (Wu and Lozano, 1994) , we addressed with the role of their viral homolog v-rel (Gilmore, 1999) , the NFB family members have been implicated in malignant transthe concern that NFB mediated upregulation of Mdm2 might simply be due to the fact that NFB upregulates p53, and p53 formation of several mammalian cell types. Defective IB␣ activity and constitutive IKK activity have been mechanistically linked in turn upregulates Mdm2. However, we do not believe that this is the case since we do not see increased p53 protein levels to the persistent nuclear NFB seen in many human tumors (Rayet and Gelinas, 1999) . In our study, expression of IKK2 by overexpression of IKK2WT with or without chemotherapy ( Figure 2A , lanes 7 and 8 or Figure 4A , lanes 3 and 4), and alone was sufficient to cause persistently nuclear NFB activity (data not shown) and significantly reduced cell death and p53 titration of increasing amounts of IKK2WT at a constant dose of DoxR showed concomitant increase in Mdm2 protein without accumulation (Figure 4) . It is tempting to speculate that human tumor cells with constitutive NFB activity might exhibit a comincrease in p53 ( Figure 6C, lanes 1-6) . Further, blocking NFB using IB␣M under similar experimental conditions showed inpromised p53 response.
To evaluate the role of p53 in NFB dependent increase in creased p53 ( Figure 6C , lanes 7-12), suggesting that this increase in p53 might be a consequence of reduced mdm2 levels. Mdm2, we analyzed whether IKK2 could upregulate Mdm2 in p53 Ϫ/Ϫ MEFs ( Figure 6B ). Using WT MEFs as matched controls, Finally, the demonstration that lack of NFB activity does not compromise the ability of DoxR to induce p53 ( Figure 1B ) sugwe showed that IKK2WT overexpression upregulates Mdm2 protein ( Figure 6B ) and RNA (data not shown) in WT but not in gests that NFB-mediated upregulation of Mdm2 is not merely intronic mdm2 promoter (Ouchi et al., 1998) 
(data not shown)
Actin was used as loading control in all experiments.
and results presented in Figure 7D , we suggest that Mdm2 might not be a direct transcriptional target of NFB. Alternatively, the upregulation of Mdm2 mRNA by NFB might occur by posttranscriptional mechanisms. The only such mechanism that has reflective of its increased transcription due to enhanced p53 been reported (Hsing et al., 2000) has been documented to protein levels.
operate in a p53-independent manner. Given that IKK2-medi-A model based on results obtained in this study is presented ated upregulation of Mdm2 mRNA requires p53, which is crucial in Figure 8 . We show that treatment with anticancer drugs actifor Mdm2 transcription, we believe that IKK2-mediated effects vates p53 (Figure 1 ) and NFB (Figure 3) . Activation of NFB are more likely to operate at transcriptional level. Recently, p63 occurs selectively through IKK2 (Figure 3) . NFB cooperates and p73 have been shown to modulate p53-dependent tranwith p53 and upregulates Mdm2 by increasing its RNA (Figure scription (Flores et al., 2002) . Similarly, NFB might be a positive 7) and protein ( Figure 6 ) levels. There are at least two lines modulator of p53-dependent transcription of Mdm2 and might of evidence that suggest that IKK2 positively modulates the be required to recruit chromatin remodeling complexes in a p53 expression of Mdm2. First, basal levels of Mdm2 RNA are lower dependent manner. The lack of this positive modulation of p53 in IKK1/2 Ϫ/Ϫ ( Figure 7A ) and p65 Ϫ/Ϫ (data not shown) cells, and dependent transcription of Mdm2 in IKK1/2 Ϫ/Ϫ MEFs might rethey can be upregulated by reconstitution of IKK2WT but not sult in lower levels of Mdm2 ( Figure 7A ) and thus greater sensitiv-IKK2KM ( Figure 7C ). Second, in response to DoxR, IKK1/2 Ϫ/Ϫ ity to p53 stabilization and cell death (Figure 1 ). cells expressing IKK2WT have comparable or higher Mdm2
In contrast to our study, p53-mediated apoptosis was re- (Figure 7E ), despite the fact that they have very low levels of ported to require NFB activation (Ryan et al., 2000) . In our p53 protein (Figure 4 , compare lanes 2, 4, and 6). It is conceivassays, recombinant adenovirus (rAdp53) mediated overexpression of p53 activated Mdm2, p21, and Bax in both WT and able that instead of a direct cooperation between these factors, by homologous recombination in 293 cells (Miyake et al., 1996) (Harvey and Levine, 1991) . The existence of 1% milk. mutated p53 in p65 Ϫ/Ϫ MEFs would be consistent with decreased sensitivity of these MEFs to DoxR (Ryan et al., 2000) .
Electrophoretic mobility shift assay
Additionally, this might explain the extremely low levels of Mdm2
Nuclear extracts were prepared as described previously (Li et al., 1999b) . Cells were washed in ice-cold PBS, scraped off the dish, and lysed for 10 mRNA observed in these cells (data not shown). mM PMSF, and 0.5 mM DTT), and vortexed for 10 s. Lysed nuclei were centrifuged for 10 min at 12,000 ϫ g, and the resulting supernatants were Experimental procedures referred to as nuclear extracts. The DNA binding reaction was performed at room temperature in a volume of 20 l, which contained the binding buffer Cell culture (25 mM Tris-HCl [pH 7.5], 1.5 mM EDTA, 7.5% glycerol, 75 mM NaCl, 1.5 Spontaneously immortalized murine embryo fibroblasts were cultured in mM DTT, 0.3% NP-40, and 1 mg/ml BSA), 1 g of poly (dI-dC), probe, and DMEM supplemented with 10% FCS (Hyclone), 100 g/ml penicillin, 100 7-10 g of nuclear proteins. After incubation with the radiolabeled probe g/ml streptomycin, and 250 ng/ml of amphotericin B (Gibco). Doxorubicin for 30 min, the samples were fractionated on a 4% polyacrylamide gel was purchased from Sigma and dissolved in Milli Q water at a concentration and visualized by autoradiography. The NFB and Oct-1 probes have been of 10 mg/ml as stock. Etoposide (Calbiochem) was reconstituted in DMSO described previously (Li et al., 1999b) . and stored at -20ЊC.
Cell survival assays Retrovirus generation and stable cell selection
Cells typically were plated in six-well dishes. Confluent cells were treated Twenty micrograms of vector plasmid was transfected with 5 g of an with DoxR (0.7 g/ml) for 60-72 hr. To estimate the percentage of survival, expression vector for vesicular stomatitis virus G protein and 1 g of a cells were stained with 0.05% crystal violet (w/v in 20% methanol) for 10 GFP expression plasmid into a cell line 293 gp/bsr (N. Somia and I.M.V., min. The excess stain was later washed off with water. The stain retained unpublished data). Supernatants containing the viruses were recovered 48 by surviving cells was leached in methanol and read immediately at 595 nm and 72 hr later, filtered through a 0.45 micron filter, and used to infect MEFs using a spectrophotometer. The untreated samples in each cell type were on three to six successive days. Freshly infected cells were stably selected considered as 100% survival, and percentage cell survival was quantitated on hygromycin (200 g/ml).
based on survival of untreated samples.
Antibodies
Northern blot analysis The murine p53 antibody PA421 used to measure total p53 in all the assays Total RNA was isolated by TRIzol reagent (GibcoBRL) and quantitated by shown was obtained from Calbiochem (clone PA421). The specificity of the spectrophotometry. For Northern blot analysis, samples were resolved on p53 immunoreactivity of this antibody was cross-confirmed by using the 1% formaldehyde gels and blotted onto Hybond Nϩ membranes (Amersham FL-393 antibody (Santacruz Biotechnology). The Phospho-p53 (Ser 15) 16G8 Pharmacia). Following crosslinking, the membranes were hybridized to the antibody, which recognizes only serine 18 phosphorylated murine p53, was probes in QuikHyb hybridization solution using the manufacturers instrucobtained from New England Biolabs. Anti-␤actin antibody (Sigma) was used tions (Stratagene). to detect levels of actin, which served as loading controls in all the experiments. The antibodies against IKK1 (M-280), IKK2 (H470), p65 (C-20), IB␣ (C-21), IB␤ (C-20), Mdm2 (SMP14), and p21 (H-164) were all from Santacruz Acknowledgments Biotechnology. Detection of flag-tagged IKK2 was performed using the Flag-M2 monoclonal antibody (F3165) from Sigma. IKK1WT and IKK1KM proteins We thank Masahito Ikawa for valuable reagents and advice. V.T. is supported were detected using anti HA antibody (12CA5).
by a career development fellowship from the Leukemia and Lymphoma Society. G.W. is supported by grants from the NIH and the Mathers Charitable Foundation. I.M.V. is an American Cancer Society Professor of Molecular Adenovirus production and infections The rAD expression cassettes carrying the CMV IE enhancer, chicken ␤-actin Biology and is supported by grants from the NIH, the March of Dimes, the Wayne and Gladys Valley Foundation, and the H.N. and Frances C. Berger promoter, and rabbit ␤-globin poly A signal were used to express GFP, IKK1WT, IKK1KM, IKK2WT, and IKK2KM proteins. Viruses were generated Foundation.
